MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers18111773

Медицинская библиотека · Cancers · 2026

Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing Study.

Bertolaccini Luca, Lombardi Mariano, Chiari Matteo, Rappa Alessandra, Casiraghi Monica, D'Ercole Marianna, Mazzella Antonio, Lo Iacono Giorgio, Mohamed Shehab, Midolo De Luca Valeria, Fusco Nicola, Guerini Rocco Elena, Spaggiari Lorenzo

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The molecular concordance between primary lung adenocarcinoma and metastatic lesions remains incompletely characterized despite its direct implications for precision oncology and biopsy-driven therapeutic decision-making. This prospective monocentric paired-sample study evaluated genomic concordance between primary lung adenocarcinoma and synchronous thoracic metastatic lesions using targeted next-generation sequencing (NGS).

METHODS

We identified 27 treatment-naïve patients with histologically confirmed lung adenocarcinoma who underwent paired molecular profiling of the primary tumor and a synchronous thoracic metastatic site (pleural or intrapulmonary). DNA and RNA were analyzed using validated institutional NGS platforms. Genomic alterations, including clinically actionable oncogenic drivers consistently covered by the sequencing panel used in each pair, were compared across matched samples. Concordance was assessed using exact binomial confidence intervals, Cohen's κ statistics, McNemar tests, and paired Wilcoxon signed-rank tests.

RESULTS

Actionable driver alterations were identified in 17 of 27 patients (63.0%; 95% CI 42.4-80.6), including EGFR mutations (40.7%), KRAS alterations (18.5%), and one ALK gene rearrangement (3.7%). TP53 concurrent mutations were detected in 14 cases (51.9%). Across all 27 paired samples, driver-level concordance was 100% (95% CI 87.2-100), with perfect agreement for EGFR, KRAS, and ALK alterations (κ = 1.00). TP53 mutations showed high concordance (92.9%; κ = 0.85), while CNVs were concordant in 88.0% of evaluable pairs. Variant allele frequency (VAF) comparisons, adjusted for tumor cellularity, further supported the apparent clonal stability of driver alterations across paired samples.

CONCLUSIONS

This study demonstrates very high molecular concordance between primary lung adenocarcinomas and their synchronous pleural or intrapulmonary metastases. The observed 100% concordance of actionable driver alterations across paired specimens supports the clinical reliability of thoracic metastatic biopsies for baseline molecular profiling in treatment-naïve disease. Although limited by sample size, these findings support the biological stability of actionable driver alterations during early thoracic metastatic dissemination.

Для цитирования: Bertolaccini Luca, Lombardi Mariano, Chiari Matteo, Rappa Alessandra, Casiraghi Monica, D'Ercole Marianna, Mazzella Antonio, Lo Iacono Giorgio, Mohamed Shehab, Midolo De Luca Valeria, Fusco Nicola, Guerini Rocco Elena, Spaggiari Lorenzo. Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing Study.. Cancers. 2026. DOI: 10.3390/cancers18111773.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.